Search
MSK scientists and doctors have the most innovative tools at their disposal to make discoveries and develop better treatments.
In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan Kettering Cancer Center have developed a new prognostic tool that is more accurate than any previously available for this disease.
Memorial Sloan Kettering Cancer Center (MSK) will further enhance its ability to offer top cancer care to even more patients with the establishment of a freestanding, state-of-the-art outpatient treatment center in Bergen County, New Jersey. Residents from communities across northern New Jersey and southern New York State will have easier access to MSK’s unique expertise when MSK Bergen becomes fully operational in winter 2017.
Could an implantable IUD help detect cancer early, when it is most curable? Scientists at the Sloan Kettering Institute are betting yes.
Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation proudly announce that eight distinguished MSK nurses and one nursing team were honored with the 2024 Robbins Family Award for Nursing Excellence. The awards coincide with National Nurses Week (May 6 – 12).
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Read up on the latest developments in several key areas of cancer research, including genomic mapping, disease modeling through CRISPR, CAR T therapy, and cancer stem cells.
Read why MSK’s medical team is the best in the nation at treating gynecologic cancers.
Combining checkpoint blockade with engineered T cells may lead to longer-lasting results in patients with breast cancer, lung cancer, and other solid tumors.
Learn about MSK's specialty in treating neuroendocrine cancers.